A quality defect was identified involving excessively high oxycodone hydrochloride content in certain Oxylaxon prolonged-release tablet batches, caused by abnormal parameters of granulate batch EE03807. Potential effects: opioid overdose, respiratory depression, poisoning.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Oxylaxon from the listed batches, check the batch number on the package, and return any affected packs to the pharmacy; in case of doubt or symptoms of overdose, consult a doctor.
Withdrawal from the market throughout the country of specified Oxylaxon batches, prohibition of placing on the market all batches manufactured from granulate EE03807, and granting the decision immedia...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related